In vivo studies using MARCO deficiency mice demonstrated significant tumor growth suppression that was associated with marked reduction of intratumoral M-MDSCs and M2-like TAMs, and enhanced accumulation of CD8+ T cells and NK cells. Here, CD8A is linked to neoplasm.